| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/17/2008 | US7387777 Methods of treating hemophilia or von willebrand disease with p-selectin |
| 06/17/2008 | US7387271 Immunostimulatory combinations |
| 06/17/2008 | CA2439152C Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/17/2008 | CA2393749C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 06/17/2008 | CA2303884C Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 06/17/2008 | CA2294457C Pharmaceutical composition for application to mucosa |
| 06/12/2008 | WO2008070011A2 Combination of an hdac inhibitor and an antimetabolite |
| 06/12/2008 | WO2008069911A2 Dual composition with warming and analgesic effects |
| 06/12/2008 | WO2008068763A2 Mixture and method for reducing cholesterol using hydrophobic chitosan microparticles |
| 06/12/2008 | WO2008068621A2 Combination product with ido inhibitor and tumor targeted ifn-gamma |
| 06/12/2008 | WO2008068548A1 Use of inhibitors of the glycosylation process for the prevention and treatment of genetic diseases |
| 06/12/2008 | WO2008003514A3 Human il-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy |
| 06/12/2008 | WO2007005879A3 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| 06/12/2008 | US20080140138 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139786 Exposing azo, azide and sulfenate agents to visible or infrared light; use in medical procedures to cause necrosis or apoptosis of tissue |
| 06/12/2008 | US20080139674 Active ingredient in electrokinetically oxygen enriched aqueous fluid; hydrogen peroxide free; preventing infection, decreasing scarring |
| 06/12/2008 | US20080139669 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 06/12/2008 | US20080139662 Such as 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol |
| 06/12/2008 | US20080139659 Reducing intracranial pressure with sulfonylurea receptor 1 antagonist |
| 06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
| 06/12/2008 | US20080139544 Modulators of CCR5(chemokine) receptors; lymphadenopathy associated and human T-cell leukemia/lymphoma viruses; AIDS infections; autoimmune diseases; antiinflammatory agents; derivatives of 1-oxa-3,8-diaza-spiro[4.5]decan-2-one and 1-oxa-3,9-diaza-spiro[5.5]undecan-2-one |
| 06/12/2008 | US20080139522 Dexamethasone disodium phosphate;xanthan gum; sodium (di)hydrogen phosphate buffer; sodium citrate; and water; ophthalmology; vision defects; corneal epithelial cells; wound healing agents |
| 06/12/2008 | US20080139502 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/12/2008 | US20080139496 Minimising dosage required of chemotherapeutic agents for their use in antiviral, antibacterial, antiparasitic and anticancer chemotherapy; for treating neoplasms and tumours, viral, bacterial, or parasite infections |
| 06/12/2008 | US20080139495 Synergistic mixture of dipyrido[2,3-b; 3,2f][1-4]diaxepines and 3'-deoxy-3'-fluorothymidine, -cytosine, -adenosine, or guanosine type derivatives; human retrovirus (HRV), hepatitis B virus (HBV), human T-cell leukemia/lymphoma virus, AIDS |
| 06/12/2008 | US20080139480 Imatinib resistant leukemia; synergistic treatment with such as ciclopirox |
| 06/12/2008 | US20080139476 Caspase-8 interacting proteins |
| 06/12/2008 | US20080138436 Food Supplement Composition Suitable For Promoting Iron Absorption |
| 06/12/2008 | US20080138426 Remedies for sex hormone dependent disease |
| 06/12/2008 | US20080138424 Fibrate particles having average particle size of less than 2000 nm; and a surface stabilizer; reduced fed/fasted variability |
| 06/12/2008 | US20080138422 Analgesic agents, controlled release to provide a rapid onset of analgesic effect, also delayed and/or sustained release; amitriptyline, gabapentin; sleep disorders |
| 06/12/2008 | US20080138396 rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis |
| 06/12/2008 | US20080138382 Biocompatible intraocular implants include a steroid and a polymer; biodegradable; eye implantable drug delivery systems; few or no negative side effects |
| 06/12/2008 | US20080138364 Injection of botulinum toxin types A, B, C1, D, E, F or G as analgesic for diabetes- or cancer-associated pain not associated with headache or muscle spasm |
| 06/12/2008 | US20080138347 Dsp-10 dual-specificity phosphatase |
| 06/12/2008 | US20080138345 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/12/2008 | US20080138333 Internalizing anti-cd74 antibodies and methods of use |
| 06/12/2008 | US20080138331 Using uterine tumor specific marker as diagnostic tool in detection of urogenital specific cell proliferative disorders |
| 06/12/2008 | US20080138322 Pretreating with lipophilic substituted saccharide |
| 06/12/2008 | US20080138320 Method of using a probiotic agent for the treatment of diarrhea |
| 06/12/2008 | US20080138317 Monoglycerides; polyethers; antidiabetic agents; rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, asthma, acute respiratory distress syndrome, chronic obstructive pulmonary disease, and multiple sclerosis |
| 06/12/2008 | US20080138313 Methods and compositions based on diphtheria toxin-interleukin-3 conjugates |
| 06/12/2008 | CA2671177A1 Mixture and method for reducing cholesterol using hydrophobic microparticles |
| 06/12/2008 | CA2670741A1 Combination of an hdac inhibitor and an antimetabolite |
| 06/11/2008 | EP1930406A1 Brain-migrating cell and use thereof |
| 06/11/2008 | EP1930340A1 Antiproliferative activity of G-rich oligonucleotides and method of using the same to bind to nucleolin |
| 06/11/2008 | EP1930308A1 Pharmaceutical agents for the treatment of cerebral amyloidosis |
| 06/11/2008 | EP1930027A2 A composition of sodium channel blocking compound |
| 06/11/2008 | EP1930023A2 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 06/11/2008 | EP1930022A1 Treatment of bladder fibrosis with antibodies against alpha V beta 6 integrin |
| 06/11/2008 | EP1930000A1 Combination of organic compounds |
| 06/11/2008 | EP1929297A2 Biomarkers for multiple sclerosis and methods of use thereof |
| 06/11/2008 | EP1929291A2 Estriol therapy for autoimmune and neurodegenerataive diseases and disorders |
| 06/11/2008 | EP1928500A2 Modulation of tlr-mediated immune responses using adaptor oligonucleotides |
| 06/11/2008 | EP1928499A1 Use of a dpp-iv inhibitor to reduce hypoglycemic events |
| 06/11/2008 | EP1928477A2 Antimicrobial medical product method for production and use thereof |
| 06/11/2008 | EP1928468A2 Estriol therapy for autoimmune and neurodegenerative diseases and disorders |
| 06/11/2008 | EP1928453A2 Methods and compositions for the preventioin and treatment of kidney disease |
| 06/11/2008 | EP1928446A2 Milnacipran for the long-term treatment of fibromyalgia syndrome |
| 06/11/2008 | EP1928438A2 Use of ibudilast for treating drug and behavioral addictions |
| 06/11/2008 | EP1928349A2 Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
| 06/11/2008 | EP1928235A2 Composition and method for use in cartilage affecting conditions |
| 06/11/2008 | EP1720540B1 Satraplatin for treating resistant or refractory tumors |
| 06/11/2008 | EP1451184B1 Dimeric compounds and their use as anti-viral agents |
| 06/11/2008 | EP1451182B1 Dimeric compounds and their use as anti-viral agents |
| 06/11/2008 | EP1444235B1 Reverse-turn mimetics and method relating thereto |
| 06/11/2008 | EP1443816B1 Methods of treating disorders related to apoe |
| 06/11/2008 | EP1420769B1 Lipid profile modulation with steroids and ppar alpha agonists |
| 06/11/2008 | EP1282436B1 Treatment of acute coronary syndrome with glp-1 |
| 06/11/2008 | EP1239885B1 Interventions to mimic the effects of calorie restriction |
| 06/11/2008 | EP1197227B9 Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method |
| 06/11/2008 | EP1165113B1 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 06/11/2008 | EP1086137B1 Composition and method for modulating dendritic cell-t cell interaction |
| 06/11/2008 | CN101198869A Agent for preventing and treating pancreatitis |
| 06/11/2008 | CN101198355A Agent for prevention or treatment of glaucoma |
| 06/11/2008 | CN101198354A Preventive or remedy for glaucoma |
| 06/11/2008 | CN101198326A Combined pharmaceutical preparation for treatment of type 2 diabetes |
| 06/11/2008 | CN101198323A Therapeutic combinations for the treatment or prevention of psychotic disorders |
| 06/11/2008 | CN101198320A Herpesvirus-derived therapeutic agent for pain |
| 06/11/2008 | CN101195029A Application method of nitric oxide donator in enteron mucosal disease |
| 06/11/2008 | CN101195028A Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/2008 | CN101195025A Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives |
| 06/11/2008 | CN100393360C Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis |
| 06/11/2008 | CN100393359C Multi-element composition for eliminating pylorus spiro-bacillus |
| 06/11/2008 | CN100393322C Separate type medical material |
| 06/11/2008 | CN100393302C Controlled releasing penetrant pump preparation for insoluble medicine composition |
| 06/11/2008 | CN100393243C Nutritional compositions |
| 06/10/2008 | USRE40374 immunomodulators comprising interleukins, Flt-3 ligands, CD antigens, interferons, colony stimulating factors, nucleotides and proteins coded by such nucleotides, antibodies raised against such proteins, used to elicit immune responses in mammals |
| 06/10/2008 | US7385035 Cytotoxic protein and utilization thereof |
| 06/10/2008 | US7385026 Modified ghrelin polypeptides |
| 06/10/2008 | US7384981 Preparation for improving the action of receptors |
| 06/10/2008 | US7384976 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 06/10/2008 | US7384967 Aryl carbonyl derivatives as therapeutic agents |
| 06/10/2008 | US7384949 For therapy and prophylaxis of disorder in which the blocking of purine receptors, particularly adenosine receptors and more may be beneficial, such a Parkinson's disease or depression, cognitive or memory impairment, pain |
| 06/10/2008 | US7384948 Graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides |
| 06/10/2008 | US7384944 Organ grafting; antiarthritic agents; inflammatory bowel disease |
| 06/10/2008 | US7384942 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/10/2008 | US7384940 Calibration kinase resistance; anticancer agents |
| 06/10/2008 | US7384912 Administering parathyroid hormone-related protein intermittently at a dosage of at least 500 mu g/day for at least one month,to increase bone mass densityat a rate of at least 1% per month; treating osteoporosis |